TEVA PHARMA IND revenue breakdown overview

TEVA PHARMA IND revenue for the last year amounted to 15.03 B CHF, the most of which — 15.03 B CHF — came from its highest performing source at the moment, Generics, Innovative Medicines and Biopharmaceuticals, the year earlier bringing 13.34 B CHF. The greatest contribution to the revenue figure was made by United States — last year it brought TEVA PHARMA IND 7.30 B CHF, and the year before that — 6.84 B CHF.